Appendix 2—table 19. “Bone-Rx” Cohort (Region=Midwest), Patient Characteristics Pre/Post Match.
| "Bone-Rx" Cohort / Region=Midwest Unmatched | "Bone-Rx" Cohort / Region=Midwest Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-user | BP User | p-value | All | BP Non-user | BP User | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 85,391 | 100.0% | 9,424 | 11.0% | 75,967 | 89.0% | 18,720 | 100.0% | 9,360 | 50.0% | 9,360 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 274 | 0.3% | ≤10 | 0.1% | 268 | 0.4% | <0.001 | 13 | 0.1% | ≤10 | 0.1% | ≤10 | 0.1% | 1.00 |
| 21-40 | 672 | 0.8% | 79 | 0.8% | 593 | 0.8% | 154 | 0.8% | 78 | 0.8% | 76 | 0.8% | ||
| 41-50 | 1,886 | 2.2% | 202 | 2.1% | 1,684 | 2.2% | 389 | 2.1% | 200 | 2.1% | 189 | 2.0% | ||
| 51-60 | 13,522 | 15.8% | 1,284 | 13.6% | 12,238 | 16.1% | 2,559 | 13.7% | 1,280 | 13.7% | 1,279 | 13.7% | ||
| 61-70 | 31,256 | 36.6% | 2,760 | 29.3% | 28,496 | 37.5% | 5,512 | 29.4% | 2,754 | 29.4% | 2,758 | 29.5% | ||
| 71-80 | 23,887 | 28.0% | 2,766 | 29.4% | 21,121 | 27.8% | 5,492 | 29.3% | 2,748 | 29.4% | 2,744 | 29.3% | ||
| ≥81 | 13,894 | 16.3% | 2,327 | 24.7% | 11,567 | 15.2% | 4,601 | 24.6% | 2,294 | 24.5% | 2,307 | 24.6% | ||
| Gender | ||||||||||||||
| Female | 76,696 | 89.8% | 8,118 | 86.1% | 68,578 | 90.3% | <0.001 | 16,223 | 86.7% | 8,102 | 86.6% | 8,121 | 86.8% | 0.68 |
| Male | 8,695 | 10.2% | 1,306 | 13.9% | 7,389 | 9.7% | 2,497 | 13.3% | 1,258 | 13.4% | 1,239 | 13.2% | ||
| Insurance | ||||||||||||||
| Commercial | 34,494 | 40.4% | 3,361 | 35.7% | 31,133 | 41.0% | <0.001 | 6,699 | 35.8% | 3,345 | 35.7% | 3,354 | 35.8% | 0.96 |
| Dual | 4,042 | 4.7% | 436 | 4.6% | 3,606 | 4.7% | 852 | 4.6% | 429 | 4.6% | 423 | 4.5% | ||
| Medicaid | 8,856 | 10.4% | 733 | 7.8% | 8,123 | 10.7% | 1,441 | 7.7% | 729 | 7.8% | 712 | 7.6% | ||
| Medicare | 37,999 | 44.5% | 4,894 | 51.9% | 33,105 | 43.6% | 9,728 | 52.0% | 4,857 | 51.9% | 4,871 | 52.0% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 32,037 | 37.5% | 3,330 | 35.3% | 28,707 | 37.8% | <0.001 | 6,628 | 35.4% | 3,312 | 35.4% | 3,316 | 35.4% | 0.95 |
| Yes | 53,354 | 62.5% | 6,094 | 64.7% | 47,260 | 62.2% | 12,092 | 64.6% | 6,048 | 64.6% | 6,044 | 64.6% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 1.12 | 2.02 | 2.12 | 2.83 | 0.99 | 1.86 | <0.001 | 2.05 | 2.72 | 2.06 | 2.72 | 2.05 | 2.72 | 0.91 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.